Medications for Panic Disorder
Other names:
Panic; Panic Attacks
What is Panic Disorder:
Symptoms of panic attack usually begin abruptly and include rapid heartbeat, chest sensations, shortness of breath, dizziness, tingling, and anxiousness. Treatments include several medications and psychotherapy.
See also:
sub-topics
Medications to treat Panic Disorder
The following list of medications are in some way related to, or
used in the treatment of this condition.
|
Drug name
|
Rx / OTC
|
Preg
|
CSA
|
Alcohol |
Reviews
|
Rating
|
Popularity
|
|
Prozac Weekly
|
Rx
|
C
|
N
|
X
|
Add review
|
Add
|
|
|
Generic name: fluoxetine systemic
Drug class:
selective serotonin reuptake inhibitors
For consumers:
dosage,
interactions,
side effects
For professionals:
Prescribing Information
|
| |
|
Vanspar
|
Rx
|
B
|
N
|
X
|
Add review
|
Add
|
|
|
Generic name: buspirone systemic
Drug class:
miscellaneous anxiolytics, sedatives and hypnotics
For consumers:
dosage,
interactions,
side effects
|
| |
|
Rapiflux
|
Rx
|
C
|
N
|
X
|
Add review
|
Add
|
|
|
Generic name: fluoxetine systemic
Drug class:
selective serotonin reuptake inhibitors
For consumers:
dosage,
interactions,
side effects
|
| |
|
nortriptyline
Off Label
|
Rx
|
N
|
N
|
X
|
3 reviews
|
8.0
|
|
|
Generic name: nortriptyline systemic
Drug class:
tricyclic antidepressants
For consumers:
dosage,
interactions,
side effects
For professionals:
A-Z Drug Facts,
AHFS DI Monograph,
Prescribing Information
Off Label:
Yes
|
| |
|
Pexeva
|
Rx
|
D
|
N
|
X
|
Add review
|
5.0
|
|
|
Generic name: paroxetine systemic
Drug class:
selective serotonin reuptake inhibitors
For consumers:
dosage,
interactions,
side effects
For professionals:
Prescribing Information
|
| |
|
clomipramine
|
Rx
|
C
|
N
|
X
|
16 reviews
|
9.0
|
|
|
Generic name: clomipramine systemic
Brand name:
Anafranil
Drug class:
tricyclic antidepressants
For consumers:
dosage,
interactions,
side effects
For professionals:
A-Z Drug Facts,
AHFS DI Monograph,
Prescribing Information
|
| |
|
imipramine
Off Label
|
Rx
|
N
|
N
|
X
|
13 reviews
|
7.0
|
|
|
Generic name: imipramine systemic
Drug class:
tricyclic antidepressants
For consumers:
dosage,
interactions,
side effects
For professionals:
A-Z Drug Facts,
AHFS DI Monograph,
Prescribing Information
Off Label:
Yes
|
| |
|
chlordiazepoxide
Off Label
|
Rx
|
N
|
4
|
X
|
2 reviews
|
Add
|
|
|
Generic name: chlordiazepoxide systemic
Drug class:
benzodiazepines
For consumers:
dosage,
interactions,
side effects
For professionals:
A-Z Drug Facts,
AHFS DI Monograph,
Prescribing Information
Off Label:
Yes
|
| |
|
fluvoxamine
Off Label
|
Rx
|
C
|
N
|
X
|
Add review
|
6.0
|
|
|
Generic name: fluvoxamine systemic
Drug class:
selective serotonin reuptake inhibitors
For consumers:
dosage,
interactions,
side effects
For professionals:
A-Z Drug Facts,
AHFS DI Monograph,
Prescribing Information
Off Label:
Yes
|
| |
|
maprotiline
Off Label
|
Rx
|
B
|
N
|
X
|
3 reviews
|
7.0
|
|
|
Generic name: maprotiline systemic
Drug class:
tetracyclic antidepressants
For consumers:
dosage,
interactions,
side effects
For professionals:
A-Z Drug Facts,
AHFS DI Monograph,
Prescribing Information
Off Label:
Yes
|
| |
|
nefazodone
Off Label
|
Rx
|
C
|
N
|
X
|
3 reviews
|
9.0
|
|
|
Generic name: nefazodone systemic
Drug class:
phenylpiperazine antidepressants
For consumers:
dosage,
interactions,
side effects
For professionals:
A-Z Drug Facts,
AHFS DI Monograph,
Prescribing Information
Off Label:
Yes
|
| |
|
desvenlafaxine
Off Label
|
Rx
|
C
|
N
|
X
|
8 reviews
|
7.0
|
|
|
Generic name: desvenlafaxine systemic
Drug class:
serotonin-norepinephrine reuptake inhibitors
For consumers:
dosage,
interactions,
side effects
For professionals:
A-Z Drug Facts,
AHFS DI Monograph,
Prescribing Information
Off Label:
Yes
|
| |
Topics under Panic Disorder
Learn more about Panic Disorder
Micromedex® Care Notes
Drugs.com Health Center
Legend
| Off Label |
This medication may not be approved by the FDA for the treatment of this condition. |
| Prescription Only / Over the Counter |
| Rx |
Prescription Only |
| OTC |
Over the Counter |
| Rx/OTC |
Prescription or Over the Counter |
| Pregnancy |
| A |
Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters). |
| B |
Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women. |
| C |
Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. |
| D |
There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. |
| X |
Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits. |
| N |
FDA has not classified the drug. |
| Controlled Substances Act Schedule |
| N |
Is not subject to the Controlled Substances Act. |
| 1 |
Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision. |
| 2 |
Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence. |
| 3 |
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
| 4 |
Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
| 5 |
Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4. |
| Alcohol |
| X |
Interacts with Alcohol. |
Browse Drugs by Condition
